Tennessee · 114th Regular Session (2025-2026) · Bill

SB 817: Drugs, Prescription - As enacted, authorizes a healthcare practitioner to prescribe and a pharmacist to dispense a prescribed, bronchodilator rescue inhaler to an authorized entity to be administered to a person believed to be experiencing asthma symptoms or respiratory distress in an emergency situation, under a standing protocol from the healthcare practitioner; encourages schools in LEAs and public charter schools to keep bronchodilator rescue inhalers to be administered to students believed to be having asthma symptoms or in respiratory distress in an emergency situation. - Amends TCA Title 49; Title 53; Title 63 and Title 68.

In committee Last action May 8, 2025: Comp. became Pub. Ch. 346

Plain-language summary

SB 817 is a bill introduced in the Tennessee Senate on February 4, 2025. According to its official title, it concerns: Drugs, Prescription - As enacted, authorizes a healthcare practitioner to prescribe and a pharmacist to dispense a prescribed, bronchodilator rescue inhaler to an authorized entity to be administered to a person believed to be experiencing asthma symptoms or respiratory distress in an emergency situation, under a standing protocol from the healthcare practitioner; encourages schools in LEAs and public charter schools to keep bronchodilator rescue inhalers to be administered to students believed to be having asthma symptoms or in respiratory distress in an emergency situation. - Amends TCA Title 49; Title 53; Title 63 and Title 68. Primary sponsor: Adam Lowe (Republican). Most recent recorded action (May 8, 2025): Comp. became Pub. Ch. 346.

Sponsors

Primary sponsor: Adam Lowe (Republican).